-
Latest in Cardiology: Interventional
Left RightBleeding increased with dabigatran during RF ablation for atrial fibrillation
Reuters Health • The Doctor's Channel Daily Newscast
1:27 | Posted on Feb 6, 2012 in Cardiology, Cardiology: Interventional, Reuters Health • The Doctor's Channel Daily NewscastNEW YORK (Reuters Health) – In patients with atrial fibrillation undergoing radiofrequency catheter ablation, complication risks are higher with use of dabigatran for anticoagulation compared with uninterrupted warfarin, researchers report in the...Advantages seen with amphilimus-eluting coronary stent
Reuters Health • The Doctor's Channel Daily Newscast
1:31 | Posted on Feb 1, 2012 in Cardiology, Cardiology: Interventional, Reuters Health • The Doctor's Channel Daily NewscastNEW YORK (Reuters Health) – Late lumen loss at 6 months is smaller with the Cre8 amphilimus-eluting stent than the Taxus paclitaxel-eluting stent in de novo percutaneous coronary intervention, according to the results of a European trial reported...Early intervention for asymptomatic mitral stenosis seen beneficial
Reuters Health • The Doctor's Channel Daily Newscast
1:47 | Posted on Feb 1, 2012 in Cardiology, Cardiology: Interventional, Reuters Health • The Doctor's Channel Daily Newscast, SurgeryNEW YORK (Reuters Health) – The benefits of preemptive percutaneous mitral commissurotomy (PMC) in asymptomatic patients with moderate mitral stenosis appear to outweigh the inherent risks of the procedure, a Korean team reports in the European...Proximal balloon occlusion better than filter protection in carotid artery stenting
Reuters Health • The Doctor's Channel Daily Newscast
1:39 | Posted on Jan 31, 2012 in Cardiology, Cardiology: Interventional, Reuters Health • The Doctor's Channel Daily NewscastNEW YORK (Reuters Health) – A proximal balloon occlusion device provided better protection against cerebral emboli than a filter device during coronary artery stenting (CAS) in the first prospective randomized trial comparing the two approaches....More evidence for intracoronary over intravenous GPI in primary PCI
Reuters Health • The Doctor's Channel Daily Newscast
1:43 | Posted on Jan 31, 2012 in Cardiology, Cardiology: Interventional, Reuters Health • The Doctor's Channel Daily NewscastNEW YORK (Reuters Health) – Three cardiologists from China say intracoronary administration of a glycoprotein IIb/IIIa receptor inhibitor (GPI) “can be recommended as a preferred regimen” during primary percutaneous coronary intervention...
More in Cardiology: Interventional
Increased risk of bleeding complications when aspirin discontinued close to combined bypass and valve surgery
Reuters Health • The Doctor's Channel Daily Newscast
1:26 | Posted on Jan 26, 2012 in
Cardiology, Cardiology: Interventional, Critical Care, Neurology & Neurosurgery, Reuters Health • The Doctor's Channel Daily Newscast, Surgery
NEW YORK (Reuters Health) – Discontinuation of aspirin within 5 days of combined coronary artery bypass graft (CABG) and valve surgery is associated with an increased risk of postoperative bleeding, compared with earlier discontinuation.
“Physicians should weigh the risk of bleeding vs. the benefit for...
Sirolimus-eluting stent a good option for BMS and DES in-stent restenosis
Reuters Health • The Doctor's Channel Daily Newscast
1:50 | Posted on Jan 23, 2012 in
Cardiology, Cardiology: Interventional, Reuters Health • The Doctor's Channel Daily Newscast
NEW YORK (Reuters Health) – Percutaneous placement of a sirolimus-eluting stent (SES) is a safe and effective way to address either bare-metal (BMS) or drug-eluting (DES) in-stent restenosis, according to a report this month in JACC: Cardiovascular Interventions from an international team of interventional...
1:29 | Posted on Jan 19, 2012 in
Cardiology, Cardiology: Interventional, Reuters Health • The Doctor's Channel Daily Newscast
NEW YORK (Reuters Health) – The rate of radial artery occlusion after transradial catheterization increases with the size of arterial sheath used for the procedure, according to data from a German registry reported in the January issue of JACC: Cardiovascular Interventions.
An editorial, however, questions...
Meta-analysis provides ‘reassuring’ data on drug-eluting stents in primary PCI
1:54
|
Jan 18, 2012
Once-weekly exenatide similar to daily metformin for type 2 diabetes
1:51
|
Jan 16, 2012
Antiplatelet resistance linked to silent cerebral emboli after coronary angiography
1:56
|
Jan 16, 2012
Radial approach for primary PCI has advantages over femoral route
1:26
|
Jan 11, 2012
Percutaneous mitral leaflet repair effective for high-risk surgical patients
1:38
|
Jan 9, 2012
Bleeding risk increased with triple antithrombotic therapy after PCI for MI
1:42
|
Jan 4, 2012
Off-pump CABG better than PCI for three-vessel coronary artery disease
1:30
|
Jan 3, 2012
Optimal duration of antiplatelet therapy after stent implantation still uncertain
1:37
|
Dec 29, 2011
Intracoronary or intravenous abciximab in primary PCI?
1:50
|
Dec 20, 2011
PCI safe before transcatheter aortic valve implantation
1:30
|
Dec 13, 2011
High-dose daptomycin an option in cardiac device-related endocarditis
1:15
|
Dec 12, 2011
Not all STEMI patients should be transferred for PCI
1:39
|
Dec 7, 2011
Withholding thienopyridines advised before cardiac surgery
1:34
|
Dec 6, 2011
Effects of left ventricular and biventricular pacing similar in selected HF patients
1:55
|
Dec 5, 2011
Drug-eluting stents may have beneficial downstream effects
1:24
|
Nov 23, 2011
No long-term benefits seen with late PCI of infarct-related artery after MI
1:37
|
Nov 23, 2011
Intracoronary adenosine before PCI does not prevent myocardial injury
1:40
|
Nov 23, 2011
Outcomes good with carotid stenting before cardiac surgery
1:28
|
Nov 23, 2011
PCI an alternative to CABG for some left main CAD cases
1:54
|
Nov 12, 2011
Percutaneous mitral regurgitation repair safe in very high risk patients
1:40
|
Nov 1, 2011
